Extracellular vesicles derived from Wharton’s Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway

Triple negative breast cancer (TNBC) is associated with worse outcomes and results in high mortality; therefore, great efforts are required to find effective treatment. In the present study, we suggested a novel strategy to treat TNBC using mesenchymal stem cell (MSC)-derived extracellular vesicles...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yun-Hsuan, Vuong, Cat-Khanh, Ngo, Nhat-Hoang, Yamashita, Toshiharu, Ye, Xiucai, Futamura, Yasunori, Fukushige, Mizuho, Obata-Yasuoka, Mana, Hamada, Hiromi, Osaka, Motoo, Hiramatsu, Yuji, Sakurai, Tetsuya, Ohneda, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359975/
https://www.ncbi.nlm.nih.gov/pubmed/35941273
http://dx.doi.org/10.1038/s41598-022-17767-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359975/
https://www.ncbi.nlm.nih.gov/pubmed/35941273
http://dx.doi.org/10.1038/s41598-022-17767-y

Ejemplares similares